Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity

References

• Ghoreschi K, Laurence A, O’Shea JJ. Janus kinases in immune cell signaling. Immunol Rev 2009; 228:273 - 87; http://dx.doi.org/10.1111/j.1600-065X.2008.00754.x; PMID: 19290934
   PubMed Web of Science ®Google Scholar
• Kim JH, Bachmann RA, Chen J. Interleukin-6 and insulin resistance. Vitam Horm 2009; 80:613 - 33; http://dx.doi.org/10.1016/S0083-6729(08)00621-3; PMID: 19251052
   PubMed Web of Science ®Google Scholar
• Kiu H, Nicholson SE. Biology and significance of the JAK/STAT signalling pathways. Growth Factors 2012; 30:88 - 106; http://dx.doi.org/10.3109/08977194.2012.660936; PMID: 22339650
   PubMed Web of Science ®Google Scholar
• Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol 2012; 56:704 - 13; http://dx.doi.org/10.1016/j.jhep.2011.09.020; PMID: 22120206
   PubMed Web of Science ®Google Scholar
• Cance WG, Liu ET. Protein kinases in human breast cancer. Breast Cancer Res Treat 1995; 35:105 - 14; http://dx.doi.org/10.1007/BF00694751; PMID: 7612897
   PubMed Web of Science ®Google Scholar
• Firmbach-Kraft I, Byers M, Shows T, Dalla-Favera R, Krolewski JJ. tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 1990; 5:1329 - 36; PMID: 2216457
   PubMed Web of Science ®Google Scholar
• Harpur AG, Andres AC, Ziemiecki A, Aston RR, Wilks AF. JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene 1992; 7:1347 - 53; PMID: 1620548
   PubMed Web of Science ®Google Scholar
• Rane SG, Reddy EP. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene 1994; 9:2415 - 23; PMID: 7518579
   PubMed Web of Science ®Google Scholar
• Wilks AF. Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc Natl Acad Sci U S A 1989; 86:1603 - 7; http://dx.doi.org/10.1073/pnas.86.5.1603; PMID: 2466296
   PubMed Web of Science ®Google Scholar
• Wilks AF, Harpur AG, Kurban RR, Ralph SJ, Zürcher G, Ziemiecki A. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol Cell Biol 1991; 11:2057 - 65; PMID: 1848670
   PubMed Web of Science ®Google Scholar
• Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, et al. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 1994; 370:153 - 7; http://dx.doi.org/10.1038/370153a0; PMID: 8022486
   PubMed Web of Science ®Google Scholar
• Fu XY, Schindler C, Improta T, Aebersold R, Darnell JE Jr.. The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci U S A 1992; 89:7840 - 3; http://dx.doi.org/10.1073/pnas.89.16.7840; PMID: 1502204
   PubMed Web of Science ®Google Scholar
• Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL. An interleukin-4-induced transcription factor: IL-4 Stat. Science 1994; 265:1701 - 6; http://dx.doi.org/10.1126/science.8085155; PMID: 8085155
   PubMed Web of Science ®Google Scholar
• Mui AL, Wakao H, Harada N, O’Farrell AM, Miyajima A. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5. J Leukoc Biol 1995; 57:799 - 803; PMID: 7539031
   PubMed Web of Science ®Google Scholar
• Schindler C, Fu XY, Improta T, Aebersold R, Darnell JE Jr.. Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci U S A 1992; 89:7836 - 9; http://dx.doi.org/10.1073/pnas.89.16.7836; PMID: 1502203
   PubMed Web of Science ®Google Scholar
• Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J 1995; 14:2527 - 35; PMID: 7781605
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Quelle FW, Thierfelder WE, Kreider BL, Gilbert DJ, Jenkins NA, et al. Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol 1994; 14:4342 - 9; PMID: 8007943
   PubMed Web of Science ®Google Scholar
• Zhong Z, Wen Z, Darnell JE Jr.. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264:95 - 8; http://dx.doi.org/10.1126/science.8140422; PMID: 8140422
   PubMed Web of Science ®Google Scholar
• Fagerlund R, Mélen K, Kinnunen L, Julkunen I. Arginine/lysine-rich nuclear localization signals mediate interactions between dimeric STATs and importin alpha 5. J Biol Chem 2002; 277:30072 - 8; http://dx.doi.org/10.1074/jbc.M202943200; PMID: 12048190
   PubMed Web of Science ®Google Scholar
• Ihle JN. STATs: signal transducers and activators of transcription. Cell 1996; 84:331 - 4; http://dx.doi.org/10.1016/S0092-8674(00)81277-5; PMID: 8608586
   PubMed Web of Science ®Google Scholar
• Kawashima T, Bao YC, Minoshima Y, Nomura Y, Hatori T, Hori T, et al. A Rac GTPase-activating protein, MgcRacGAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors. Mol Cell Biol 2009; 29:1796 - 813; http://dx.doi.org/10.1128/MCB.01423-08; PMID: 19158271
   PubMed Web of Science ®Google Scholar
• Kawashima T, Bao YC, Nomura Y, Moon Y, Tonozuka Y, Minoshima Y, et al. Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. J Cell Biol 2006; 175:937 - 46; http://dx.doi.org/10.1083/jcb.200604073; PMID: 17178910
   PubMed Web of Science ®Google Scholar
• Kessler DS, Veals SA, Fu XY, Levy DE. Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev 1990; 4:1753 - 65; http://dx.doi.org/10.1101/gad.4.10.1753; PMID: 2249773
   PubMed Web of Science ®Google Scholar
• Sekimoto T, Imamoto N, Nakajima K, Hirano T, Yoneda Y. Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1. EMBO J 1997; 16:7067 - 77; http://dx.doi.org/10.1093/emboj/16.23.7067; PMID: 9384585
   PubMed Web of Science ®Google Scholar
• Shuai K, Stark GR, Kerr IM, Darnell JE Jr.. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 1993; 261:1744 - 6; http://dx.doi.org/10.1126/science.7690989; PMID: 7690989
   PubMed Web of Science ®Google Scholar
• Kile BT, Alexander WS. The suppressors of cytokine signalling (SOCS). Cell Mol Life Sci 2001; 58:1627 - 35; http://dx.doi.org/10.1007/PL00000801; PMID: 11706989
   PubMed Web of Science ®Google Scholar
• Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 2001; 19:378 - 87; http://dx.doi.org/10.1634/stemcells.19-5-378; PMID: 11553846
   PubMed Web of Science ®Google Scholar
• Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A 1998; 95:114 - 9; http://dx.doi.org/10.1073/pnas.95.1.114; PMID: 9419338
   PubMed Web of Science ®Google Scholar
• Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387:917 - 21; http://dx.doi.org/10.1038/43206; PMID: 9202125
   PubMed Web of Science ®Google Scholar
• ten Hoeve J, de Jesus Ibarra-Sanchez M, Fu Y, Zhu W, Tremblay M, David M, et al. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol 2002; 22:5662 - 8; http://dx.doi.org/10.1128/MCB.22.16.5662-5668.2002; PMID: 12138178
   PubMed Web of Science ®Google Scholar
• Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, et al. PTP1B regulates leptin signal transduction in vivo. Dev Cell 2002; 2:489 - 95; http://dx.doi.org/10.1016/S1534-5807(02)00148-X; PMID: 11970898
   PubMed Web of Science ®Google Scholar
• Shuai K. Regulation of cytokine signaling pathways by PIAS proteins. Cell Res 2006; 16:196 - 202; http://dx.doi.org/10.1038/sj.cr.7310027; PMID: 16474434
   PubMed Web of Science ®Google Scholar
• Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395:763 - 70; http://dx.doi.org/10.1038/27376; PMID: 9796811
   PubMed Web of Science ®Google Scholar
• Könner AC, Brüning JC. Selective insulin and leptin resistance in metabolic disorders. Cell Metab 2012; 16:144 - 52; http://dx.doi.org/10.1016/j.cmet.2012.07.004; PMID: 22883229
   PubMed Web of Science ®Google Scholar
• Belgardt BF, Brüning JC. CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci 2010; 1212:97 - 113; http://dx.doi.org/10.1111/j.1749-6632.2010.05799.x; PMID: 21070248
   PubMed Web of Science ®Google Scholar
• Chua SC Jr., Koutras IK, Han L, Liu SM, Kay J, Young SJ, et al. Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts. Genomics 1997; 45:264 - 70; http://dx.doi.org/10.1006/geno.1997.4962; PMID: 9344648
   PubMed Web of Science ®Google Scholar
• White DW, Kuropatwinski KK, Devos R, Baumann H, Tartaglia LA. Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J Biol Chem 1997; 272:4065 - 71; http://dx.doi.org/10.1074/jbc.272.7.4065; PMID: 9020115
   PubMed Web of Science ®Google Scholar
• Kloek C, Haq AK, Dunn SL, Lavery HJ, Banks AS, Myers MG Jr.. Regulation of Jak kinases by intracellular leptin receptor sequences. J Biol Chem 2002; 277:41547 - 55; http://dx.doi.org/10.1074/jbc.M205148200; PMID: 12196522
   PubMed Web of Science ®Google Scholar
• Ihle JN, Kerr IM. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 1995; 11:69 - 74; http://dx.doi.org/10.1016/S0168-9525(00)89000-9; PMID: 7716810
   PubMed Web of Science ®Google Scholar
• Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 1995; 268:251 - 5; http://dx.doi.org/10.1126/science.7716517; PMID: 7716517
   PubMed Web of Science ®Google Scholar
• Banks AS, Davis SM, Bates SH, Myers MG Jr.. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 2000; 275:14563 - 72; http://dx.doi.org/10.1074/jbc.275.19.14563; PMID: 10799542
   PubMed Web of Science ®Google Scholar
• Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003; 374:1 - 20; http://dx.doi.org/10.1042/BJ20030407; PMID: 12773095
   PubMed Web of Science ®Google Scholar
• Fuente-Martín E, García-Cáceres C, Granado M, de Ceballos ML, Sánchez-Garrido MA, Sarman B, et al. Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes. J Clin Invest 2012; 122:3900 - 13; http://dx.doi.org/10.1172/JCI64102; PMID: 23064363
   PubMed Web of Science ®Google Scholar
• Wang Y, Kuropatwinski KK, White DW, Hawley TS, Hawley RG, Tartaglia LA, et al. Leptin receptor action in hepatic cells. J Biol Chem 1997; 272:16216 - 23; http://dx.doi.org/10.1074/jbc.272.26.16216; PMID: 9195922
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008; 135:61 - 73; http://dx.doi.org/10.1016/j.cell.2008.07.043; PMID: 18854155
   PubMed Web of Science ®Google Scholar
• Zhang X, Hecker M, Park JW, Tompsett AR, Jones PD, Newsted J, et al. Time-dependent transcriptional profiles of genes of the hypothalamic-pituitary-gonadal axis in medaka (Oryzias latipes) exposed to fadrozole and 17beta-trenbolone. Environ Toxicol Chem 2008; 27:2504 - 11; http://dx.doi.org/10.1897/08-082.1; PMID: 18693774
   PubMed Web of Science ®Google Scholar
• Zhang X, Hecker M, Park JW, Tompsett AR, Newsted J, Nakayama K, et al. Real-time PCR array to study effects of chemicals on the Hypothalamic-Pituitary-Gonadal axis of the Japanese medaka. Aquat Toxicol 2008; 88:173 - 82; http://dx.doi.org/10.1016/j.aquatox.2008.04.009; PMID: 18534694
   PubMed Web of Science ®Google Scholar
• Bailly-Maitre B, Belgardt BF, Jordan SD, Coornaert B, von Freyend MJ, Kleinridders A, et al. Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance. J Biol Chem 2010; 285:6198 - 207; http://dx.doi.org/10.1074/jbc.M109.056648; PMID: 19996103
   PubMed Web of Science ®Google Scholar
• Butler AA, Cone RD. The melanocortin receptors: lessons from knockout models. Neuropeptides 2002; 36:77 - 84; http://dx.doi.org/10.1054/npep.2002.0890; PMID: 12359499
   PubMed Web of Science ®Google Scholar
• Tartaglia LA. The leptin receptor. J Biol Chem 1997; 272:6093 - 6; PMID: 9102398
   PubMed Web of Science ®Google Scholar
• Munzberg H. Leptin-signaling pathways and leptin resistance. Forum Nutr 2010; 63:123 - 32; http://dx.doi.org/10.1159/000264400; PMID: 19955780
   PubMed Web of Science ®Google Scholar
• Bjørbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998; 1:619 - 25; http://dx.doi.org/10.1016/S1097-2765(00)80062-3; PMID: 9660946
   PubMed Web of Science ®Google Scholar
• Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjørbaek C, Flier JS. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 2004; 10:734 - 8; http://dx.doi.org/10.1038/nm1072; PMID: 15220914
   PubMed Web of Science ®Google Scholar
• Marine JC, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, et al. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 1999; 98:617 - 27; http://dx.doi.org/10.1016/S0092-8674(00)80049-5; PMID: 10490101
   PubMed Web of Science ®Google Scholar
• Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, et al. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci U S A 2001; 98:9324 - 9; http://dx.doi.org/10.1073/pnas.161271798; PMID: 11481489
   PubMed Web of Science ®Google Scholar
• Balthasar N, Coppari R, McMinn J, Liu SM, Lee CE, Tang V, et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 2004; 42:983 - 91; http://dx.doi.org/10.1016/j.neuron.2004.06.004; PMID: 15207242
   PubMed Web of Science ®Google Scholar
• Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB, et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006; 51:801 - 10; http://dx.doi.org/10.1016/j.neuron.2006.08.023; PMID: 16982424
   PubMed Web of Science ®Google Scholar
• Ernst MB, Wunderlich CM, Hess S, Paehler M, Mesaros A, Koralov SB, et al. Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity. J Neurosci 2009; 29:11582 - 93; http://dx.doi.org/10.1523/JNEUROSCI.5712-08.2009; PMID: 19759305
   PubMed Web of Science ®Google Scholar
• Mesaros A, Koralov SB, Rother E, Wunderlich FT, Ernst MB, Barsh GS, et al. Activation of Stat3 signaling in AgRP neurons promotes locomotor activity. Cell Metab 2008; 7:236 - 48; http://dx.doi.org/10.1016/j.cmet.2008.01.007; PMID: 18316029
   PubMed Web of Science ®Google Scholar
• Smith CC, Dixon RA, Wynne AM, Theodorou L, Ong SG, Subrayan S, et al. Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol 2010; 299:H1265 - 70; http://dx.doi.org/10.1152/ajpheart.00092.2010; PMID: 20656889
   PubMedGoogle Scholar
• Lecour S, Suleman N, Deuchar GA, Somers S, Lacerda L, Huisamen B, et al. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 2005; 112:3911 - 8; http://dx.doi.org/10.1161/CIRCULATIONAHA.105.581058; PMID: 16344382
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 2003; 27:Suppl 3 S53 - 5; http://dx.doi.org/10.1038/sj.ijo.0802502; PMID: 14704746
   PubMed Web of Science ®Google Scholar
• Kleinridders A, Schenten D, Könner AC, Belgardt BF, Mauer J, Okamura T, et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab 2009; 10:249 - 59; http://dx.doi.org/10.1016/j.cmet.2009.08.013; PMID: 19808018
   PubMed Web of Science ®Google Scholar
• Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998; 22:1145 - 58; http://dx.doi.org/10.1038/sj.ijo.0800770; PMID: 9877249
   PubMed Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr.. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796 - 808; PMID: 14679176
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115:1111 - 9; PMID: 15864338
   PubMed Web of Science ®Google Scholar
• Wunderlich CM, Delić D, Behnke K, Meryk A, Ströhle P, Chaurasia B, et al. Cutting edge: Inhibition of IL-6 trans-signaling protects from malaria-induced lethality in mice. J Immunol 2012; 188:4141 - 4; http://dx.doi.org/10.4049/jimmunol.1102137; PMID: 22467660
   PubMed Web of Science ®Google Scholar
• Scheller J, Rose-John S. Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol 2006; 195:173 - 83; http://dx.doi.org/10.1007/s00430-006-0019-9; PMID: 16741736
   PubMed Web of Science ®Google Scholar
• Roytblat L, Rachinsky M, Fisher A, Greemberg L, Shapira Y, Douvdevani A, et al. Raised interleukin-6 levels in obese patients. Obes Res 2000; 8:673 - 5; http://dx.doi.org/10.1038/oby.2000.86; PMID: 11225716
   PubMedGoogle Scholar
• Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327 - 34; http://dx.doi.org/10.1001/jama.286.3.327; PMID: 11466099
   PubMed Web of Science ®Google Scholar
• Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001; 9:414 - 7; http://dx.doi.org/10.1038/oby.2001.54; PMID: 11445664
   PubMedGoogle Scholar
• Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53:693 - 700; http://dx.doi.org/10.2337/diabetes.53.3.693; PMID: 14988254
   PubMed Web of Science ®Google Scholar
• Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85:3338 - 42; http://dx.doi.org/10.1210/jc.85.9.3338; PMID: 10999830
   PubMed Web of Science ®Google Scholar
• Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson SL, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8:75 - 9; http://dx.doi.org/10.1038/nm0102-75; PMID: 11786910
   PubMed Web of Science ®Google Scholar
• Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab 2004; 287:E182 - 7; http://dx.doi.org/10.1152/ajpendo.00189.2003; PMID: 15191885
   PubMed Web of Science ®Google Scholar
• Ueki K, Kondo T, Tseng YH, Kahn CR. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A 2004; 101:10422 - 7; http://dx.doi.org/10.1073/pnas.0402511101; PMID: 15240880
   PubMed Web of Science ®Google Scholar
• Ueki K, Kondo T, Kahn CR. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 2004; 24:5434 - 46; http://dx.doi.org/10.1128/MCB.24.12.5434-5446.2004; PMID: 15169905
   PubMed Web of Science ®Google Scholar
• Rui L, Yuan M, Frantz D, Shoelson S, White MF. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 2002; 277:42394 - 8; http://dx.doi.org/10.1074/jbc.C200444200; PMID: 12228220
   PubMed Web of Science ®Google Scholar
• Shi H, Tzameli I, Bjørbaek C, Flier JS. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem 2004; 279:34733 - 40; http://dx.doi.org/10.1074/jbc.M403886200; PMID: 15181014
   PubMed Web of Science ®Google Scholar
• Starr R, Metcalf D, Elefanty AG, Brysha M, Willson TA, Nicola NA, et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci U S A 1998; 95:14395 - 9; http://dx.doi.org/10.1073/pnas.95.24.14395; PMID: 9826711
   PubMed Web of Science ®Google Scholar
• Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56:1010 - 3; http://dx.doi.org/10.2337/db06-1656; PMID: 17287468
   PubMed Web of Science ®Google Scholar
• Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 2008; 322:1539 - 43; http://dx.doi.org/10.1126/science.1160794; PMID: 19056984
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, et al. Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes. J Endocrinol 2004; 181:129 - 38; http://dx.doi.org/10.1677/joe.0.1810129; PMID: 15072573
   PubMed Web of Science ®Google Scholar
• Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 2003; 311:372 - 9; http://dx.doi.org/10.1016/j.bbrc.2003.10.013; PMID: 14592424
   PubMed Web of Science ®Google Scholar
• Shi H, Cave B, Inouye K, Bjørbaek C, Flier JS. Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 2006; 55:699 - 707; http://dx.doi.org/10.2337/diabetes.55.03.06.db05-0841; PMID: 16505233
   PubMed Web of Science ®Google Scholar
• Palanivel R, Fullerton MD, Galic S, Honeyman J, Hewitt KA, Jorgensen SB, et al. Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance. Diabetologia 2012; 55:3083 - 93; http://dx.doi.org/10.1007/s00125-012-2665-3; PMID: 22872213
   PubMed Web of Science ®Google Scholar
• Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 2003; 278:13740 - 6; http://dx.doi.org/10.1074/jbc.M210689200; PMID: 12560330
   PubMed Web of Science ®Google Scholar
• Torisu T, Sato N, Yoshiga D, Kobayashi T, Yoshioka T, Mori H, et al. The dual function of hepatic SOCS3 in insulin resistance in vivo. Genes Cells 2007; 12:143 - 54; http://dx.doi.org/10.1111/j.1365-2443.2007.01044.x; PMID: 17295835
   PubMed Web of Science ®Google Scholar
• Sachithanandan N, Fam BC, Fynch S, Dzamko N, Watt MJ, Wormald S, et al. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. Hepatology 2010; 52:1632 - 42; http://dx.doi.org/10.1002/hep.23861; PMID: 20799351
   PubMed Web of Science ®Google Scholar
• Wunderlich FT, Ströhle P, Könner AC, Gruber S, Tovar S, Brönneke HS, et al. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab 2010; 12:237 - 49; http://dx.doi.org/10.1016/j.cmet.2010.06.011; PMID: 20816090
   PubMed Web of Science ®Google Scholar
• Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, Matsumoto M, et al. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab 2006; 3:267 - 75; http://dx.doi.org/10.1016/j.cmet.2006.02.009; PMID: 16581004
   PubMed Web of Science ®Google Scholar
• Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106:473 - 81; http://dx.doi.org/10.1172/JCI10842; PMID: 10953022
   PubMed Web of Science ®Google Scholar
• Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012; 8:457 - 65; http://dx.doi.org/10.1038/nrendo.2012.49; PMID: 22473333
   PubMed Web of Science ®Google Scholar
• Schéle E, Fekete C, Egri P, Füzesi T, Palkovits M, Keller E, et al. Interleukin-6 receptor α is co-localised with melanin-concentrating hormone in human and mouse hypothalamus. J Neuroendocrinol 2012; 24:930 - 43; http://dx.doi.org/10.1111/j.1365-2826.2012.02286.x; PMID: 22295972
   PubMed Web of Science ®Google Scholar
• Yang Z, Hulver M, McMillan RP, Cai L, Kershaw EE, Yu L, et al. Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS One 2012; 7:e47493; http://dx.doi.org/10.1371/journal.pone.0047493; PMID: 23115649
   PubMedGoogle Scholar
• Lebrun P, Cognard E, Bellon-Paul R, Gontard P, Filloux C, Jehl-Pietri C, et al. Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice. Diabetologia 2009; 52:2201 - 12; http://dx.doi.org/10.1007/s00125-009-1474-9; PMID: 19672574
   PubMed Web of Science ®Google Scholar
• Jorgensen SB, O'Neill HM, Sylow L, Honeyman J, Hewitt KA, Palanivel R, et al. Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity. Diabetes 2013; 62:56 - 64; http://dx.doi.org/10.2337/db12-0443; PMID: 22961088
   PubMed Web of Science ®Google Scholar